Crossmark

What We Know to Date About Early Treatment With Biologics in Severe Asthma: A Scoping Review About the Use of Biologics in Severe Asthma and Possible Parallels With Early Rheumatoid Arthritis

Crossref DOI link: https://doi.org/10.1016/j.opresp.2025.100418

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pérez-de Llano, Luis

Bonilla, Mª Gema

Luzon, Elisa

Ramos-Lima, Francisco

Miralles, Juan Carlos
Funding

Funding for this research was provided by:

AstraZeneca España
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-02-18
More Information

This article is maintained by: Elsevier

Article Title: What We Know to Date About Early Treatment With Biologics in Severe Asthma: A Scoping Review About the Use of Biologics in Severe Asthma and Possible Parallels With Early Rheumatoid Arthritis

Journal Title: Open Respiratory Archives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.opresp.2025.100418

Content Type: article

Copyright: © 2025 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below